BioSpace News Archive

Biotech Bay

Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.

Fluidigm Corporation (NASDAQ:FLDM), today announced that its Board of Directors has unanimously approved a $250 million investment by leading life sciences investors Casdin Capital, LLC (“Casdin”) and Viking Global Investors LP (“Viking”).

January 24, 2022
·
16 min read
Business

Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia

Illumina, Inc. (NASDAQ: ILMN) and the National Cancer Center Japan have announced an international joint research project that will use Illumina’s high-throughput DNA sequencing to analyse the blood-based genomic profile and clinical information of patients living with Nasopharyngeal Carcinoma.

January 24, 2022
·
4 min read
Business

InterVenn Promotes Klaus Lindpaintner to InterVenn Distinguished Scientist; Appoints Tillman Pearce as Chief Medical Officer

InterVenn Biosciences, the leader in glycoproteomics, announced the appointment of Klaus Lindpaintner, MD, MPH, to the newly created role of InterVenn Distinguished Scientist.

January 24, 2022
·
3 min read
Biotech Bay

New Data Suggest Veracyte’s Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer

Veracyte, Inc. (Nasdaq: VCYT) announced the publication of new data that suggest the company’s Percepta Genomic Sequencing Classifier (GSC) can accelerate delivery of curative therapy for patients with high-risk lung nodules and inconclusive bronchoscopy results.

January 24, 2022
·
8 min read
Lone Star Bio

Castle Biosciences to Present Data at Maui Derm for Dermatologists 2022

Castle Biosciences, Inc., a leader in transforming disease management and improving patient outcomes through innovative diagnostics, will present data highlighting its portfolio of skin cancer tests at Maui Derm for Dermatologists 2022, being held Jan. 24-28, 2022, in Maui, Hawaii.

January 24, 2022
·
7 min read
Lone Star Bio

Soleo Health Selected as Limited Distribution Partner for VYVGART™

Soleo Health announced today it was selected as a limited distribution partner for VYVGART ™ (efgartigimod alfa-fcab) by argenx SE.

January 24, 2022
·
3 min read
Genetown

Seres Therapeutics to Host Virtual Investor Event Highlighting Opportunities for Microbiome Therapeutics in Infection Protection on January 31, 2022

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it will host a webcast investor event on Monday, January 31, 2022, from 8:30 a.m. to 10:00 a.m. ET.

January 24, 2022
·
2 min read
Drug Development

KalVista Pharmaceuticals Announces Publication of Oral HAE Therapy KVD900 Phase 1 Data in Journal of Allergy and Clinical Immunology

KalVista Pharmaceuticals Announces Publication of Oral HAE Therapy KVD900 Phase 1 Data in Journal of Allergy and Clinical Immunology

January 24, 2022
·
4 min read
Biotech Bay

Codexis Announces FDA Orphan Drug and Rare Pediatric Disease Designations for CDX 6512 for the Treatment of Homocystinuria

Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation (ODD) for CDX-6512 for the treatment of homocystinuria.

January 24, 2022
·
5 min read
Biotech Beach

Allergan Aesthetics Announces Open Casting Call for BOTOX® Cosmetic (onabotulinumtoxinA)

IRVINE, Calif., Jan. 24, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) announced today it will be hosting an open casting call seeking people who would like to share their BOTOX® Cosmetic Story.

January 24, 2022
·
7 min read